Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain.

Cristina EpalzaLuis Prieto-TatoRosa PinoPaula Escartín-ParedesInés LeozCarlos Daniel Grasa LozanoAna Vivanco-AllendeJacques G RiviereJaume Carrasco-ColomOlatz VillateVictoria FumadóConcepción Hermoso-IbañezBlanca HerreroDavid Aguilera-AlonsoAlfredo TagarroCinta Moraledanull null

Published in: Journal of the Pediatric Infectious Diseases Society (2022)

In this cohort of 42 adolescents with a previous multisystem inflammatory syndrome (MIS-C) diagnosis, 32 (76.2%) were vaccinated with COVID-19 vaccines, with a low incidence of relevant adverse events. More importantly, no new MIS-C or myocarditis occurred after a median of 10 weeks (range 5.3-19.7) post-vaccination.

Keyphrases

coronavirus disease
sars cov
young adults
oxidative stress
case report
physical activity
risk factors
respiratory syndrome coronavirus
preterm birth